Reference
Peer-to-peer review prep
21 P2P prep guides by drug — what to bring, common objections, pitfalls.
Drugs covered
21
Adalimumab (Humira)
TNF inhibitor
RA, PsA, AS, Crohn's, UC, HS, psoriasis
Benralizumab (Fasenra)
Anti-IL-5Rα
Severe eosinophilic asthma
Dulaglutide (Trulicity)
GLP-1 receptor agonist
T2DM
Dupilumab (Dupixent)
IL-4/IL-13 inhibitor
Atopic dermatitis, asthma, EoE, CRSwNP
Erenumab (Aimovig)
CGRP receptor antagonist
Migraine prevention
Etanercept (Enbrel)
TNF inhibitor
RA, JIA, PsA, AS, psoriasis
Fremanezumab (Ajovy)
CGRP antagonist
Migraine prevention
Galcanezumab (Emgality)
CGRP antagonist
Migraine prevention, cluster
Infliximab (Remicade)
TNF inhibitor
RA, PsA, AS, Crohn's, UC, psoriasis
Liraglutide (Saxenda/Victoza)
GLP-1 receptor agonist
T2DM (Victoza), obesity (Saxenda)
Mepolizumab (Nucala)
Anti-IL-5
Severe eosinophilic asthma, HES, EGPA, CRSwNP
Nivolumab (Opdivo)
PD-1 inhibitor
Multiple solid tumors, hematologic
Ocrelizumab (Ocrevus)
Anti-CD20
RRMS, PPMS
Ofatumumab (Kesimpta)
Anti-CD20
RRMS
Omalizumab (Xolair)
Anti-IgE
Severe persistent allergic asthma, chronic spontaneous urticaria
Pembrolizumab (Keytruda)
PD-1 inhibitor
Multiple solid tumors
Secukinumab (Cosentyx)
IL-17A inhibitor
Psoriasis, PsA, AS
Semaglutide (Wegovy/Ozempic)
GLP-1 receptor agonist
Type 2 diabetes (Ozempic), obesity (Wegovy)
Tirzepatide (Mounjaro/Zepbound)
GLP-1/GIP dual agonist
T2DM (Mounjaro), obesity (Zepbound)
Trastuzumab (Herceptin)
Anti-HER2
HER2+ breast cancer, gastric
Ustekinumab (Stelara)
IL-12/23 inhibitor
Psoriasis, PsA, Crohn's, UC
Contact: hello@approvalhelp.com